09-01-2021, 08:48 AM
https://finance.yahoo.com/news/novavax-s...00936.html
Novavax clinical trial participants who got both shots of the actual vaccine are considered to be fully vaccinated.
Novavax appears to have had better results than J&J.
https://ir.novavax.com/2021-06-14-Novava...se-3-Trial
"100% protection against moderate and severe disease, 90.4% efficacy overall"
"Efficacy endpoints were accrued from January 25 through April 30, 2021 — a time when the Alpha (B.1.1.7) variant, first identified in the U.K., became the predominant strain in the U.S"
As of June 14, "The company intends to file for regulatory authorizations in the third quarter, upon completion of the final phases of process qualification and assay validation needed to meet chemistry, manufacturing and controls (CMC) requirements."
Novavax clinical trial participants who got both shots of the actual vaccine are considered to be fully vaccinated.
Novavax appears to have had better results than J&J.
https://ir.novavax.com/2021-06-14-Novava...se-3-Trial
"100% protection against moderate and severe disease, 90.4% efficacy overall"
"Efficacy endpoints were accrued from January 25 through April 30, 2021 — a time when the Alpha (B.1.1.7) variant, first identified in the U.K., became the predominant strain in the U.S"
As of June 14, "The company intends to file for regulatory authorizations in the third quarter, upon completion of the final phases of process qualification and assay validation needed to meet chemistry, manufacturing and controls (CMC) requirements."